Articles

  • 3 days ago | levernews.com | Jeanne Lenzer

    This article is part of an investigation into the Food and Drug Administration’s drug approval process and what it means for the public’s safety and health. The project is supported by The Lever and the McGraw Center for Business Journalism at CUNY’s Newmark Graduate School of Journalism. Read Part One here. Nieraj Jain was puzzled by the patient sitting quietly in front of him. The woman, in her 60s, was losing her eyesight; that much was clear.

  • 4 days ago | levernews.com | Jeanne Lenzer

    Curious about the science behind the medicines you’ve been prescribed — and whether that science stands up to scrutiny? As part of our investigation “FDA Approved — And Ineffective,” we compiled a searchable database of all 429 drugs approved by the U.S. Food and Drug Administration between January 2013 and Dec. 31, 2022, and the scientific evidence submitted by drugmakers to demonstrate the drugs were safe and effective. You can use the following database to evaluate drugmakers’ claims.

  • Feb 1, 2025 | jacobin.com | Jeanne Lenzer

    Six years ago, Genevieve Lane was enjoying an active life in Florida when she began to forget her neighbors’ names and where she put her keys. At seventy-six, she might have shrugged off these lapses as mere signs of aging, but when she began to have moments of confusion and occasionally got lost while out walking, her housemate and longtime friend Vicki Holmes told her about a nearby research center.

  • Jan 28, 2025 | levernews.com | Jeanne Lenzer

    This article is part of an investigation into the Food and Drug Administration’s drug approval process and what it means for the public’s safety and health. The project is supported by The Lever and the McGraw Center for Business Journalism at CUNY Newmark School of Journalism. Six years ago, Genevieve Lane was enjoying an active life in Florida when she began to forget her neighbors’ names and where she put her keys.

  • Jan 28, 2025 | levernews.com | Jeanne Lenzer

    This full story is for paid subscribers. Sign up for a paid subscription to The Lever now to gain access to this story and more. Already have an account? Sign in